Research Article
[Retracted] The Effect of the Integrated Chinese and Western Medicine for the Treatment of Parkinson’s Disease: A Meta-Analysis
Table 1
Clinical baseline information and primary conclusion of studies.
| | Study | Study design | Treatment | No. of patients | Gender (M/F) | Age | Follow-up | Duration | | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control |
| | Li Chengdong 2011 | RCT | Herbal fumigation and washing prescription+medoba | Medoba | 40 | 40 | 23/17 | 24/16 | | | 4 months | 2006 to 2010 | | Wan Fung Kum 2011 | RCT | Jia Wei Liu Jun Zi Tang+CMW | CMW | 22 | 25 | 14/8 | 17/8 | | | 24 weeks | NR | | Weidong Pan 2011 | RCT | Zeng-xiao An-shen Zhi-chan 2+CMW | CMW | 56 | 54 | 34/22 | 32/22 | | | 13 weeks | 2008 to 2010 | | Yang Qingtang 2012 | RCT | Shaoyao Gancao decoction+Ganmai Dazao decoction+medoba | Medoba | 34 | 34 | NR | NR | 45-80 | 45-80 | 12 weeks | 2009 to 2011 | | Yu Dengjun 2012 | RCT | Ginseng Guipi decoction+medoba | Medoba | 50 | 48 | NR | NR | | | 4 weeks | 2009 to 2011 | | Zhong Cheng 2012 | RCT | Bushen Huoxue Tongluo capsule+CMW | CMW | 60 | 60 | NR | NR | 51-82 | 51-82 | 3 months | 2011 to 2012 | | Chen Mengyun 2014 | RCT | Zhizhan granule+CMW | CMW | 57 | 51 | 38/19 | 35/16 | | | 12 weeks | 2012 to 2013 | | Chao Gu 2015 | RCT | Di-Huang-Yi-Zhi+donepezil | Donepezil | 30 | 30 | 14/16 | 13/17 | | | 6 months | 2010 to 2013 | | Wen Lili 2015 | RCT | Cistanche wuxifeng granule+medoba | Medoba | 29 | 28 | 15/14 | 16/12 | | | 3 months | 2013 to 2014 | | You Jiahua 2015 | RCT | Shujin dingzhan decoction+CMW | CMW | 30 | 30 | 22/8 | 20/10 | | | 12 weeks | 2013 to 2014 | | Bai Yu 2016 | RCT | Zishen RouJing decoction + CMW | CMW | 54 | 54 | 33/21 | 35/19 | | | 12 weeks | 2007 to 2015 | | Xu Qingshui 2016 | RCT | Cistanche Rongjing+levodopa | Levodopa | 14 | 10 | 8/6 | 7/3 | | | 3 months | NR | | Ye Qing 2016 | RCT | Yizhi Pingzhan recipe+levodopa | Levodopa | 40 | 38 | 25/15 | 23/15 | | | 3 months | 2013 to 2015 | | Zhang Lijuan 2016 | RCT | Qingxin Kaiqiao recipe+acupuncture+medoba | Medoba | 49 | 49 | NR | NR | | | 4 months | 2015 | | Cai Li 2017 | RCT | Zhizhan decoction+CMW | CMW | 43 | 43 | 25/18 | 23/20 | | | 12 weeks | 2014 to 2016 | | Chen Yu 2017 | RCT | Tianma goutengyin and Shaoyao Gancao decoction+medoba | Medoba | 36 | 36 | 22/14 | 21/15 | | | 3 months | 2013 to 2015 | | Wang Jiecheng 2017 | RCT | Self-made prescription+dopashydrazine | Dopashydrazine | 49 | 49 | 28/21 | 25/24 | | | 4 weeks | 2016 | | Mo Haizhen 2018 | RCT | Yishen tiaogan Jieyu recipe+dopashydrazine | Dopashydrazine | 30 | 30 | 13/17 | 11/19 | | | 8 weeks | 2016 to 2017 | | Xu Xiao 2018 | RCT | Shaoyao Gancao decoction+CMW | CMW | 30 | 30 | 16/14 | 17/13 | | | 3 months | 2014 to 2017 | | Cao Jianfeng 2020 | RCT | Dialectical prescription+levodopa | Levodopa | 45 | 45 | 29/16 | 28/17 | | | 8 weeks | 2016 to 2018 | | Liao Xun 2020 | RCT | Dialectical prescription+dopashydrazine | Dopashydrazine | 36 | 36 | 20/16 | 18/18 | | | 11 weeks | 2018 to 2019 | | Zhao Lili 2020 | RCT | Dialectical prescription+medoba | Medoba | 60 | 15 | NR | NR | NR | NR | 5 weeks | 2017 to 2019 | | Zhang Quan 2021 | RCT | Yangxue Pinggan granule+CMW | CMW | 20 | 20 | 10/10 | 11/9 | | | 8 weeks | 2017 to 2019 |
|
|
RCT: randomized controlled trail; CMW: conventional Western medicine; NR: not reported.
|